GleamWall
中文EN

NUS NU SKIN ENTERPRISES, INC.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 1021561 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-15.3%
TTM net income YoY-313.7%
TTM EPS YoY-321.9%
Revenue 3-yr CAGR-12.9%
Net income 3-yr CAGR—

Margins

Gross margin67.8%
Operating margin-2.0%
Net margin-17.7%
FCF margin-2.0%
EBITDA margin1.8%

Returns

ROE-34.8%
ROA-18.6%
ROIC (approx.)-3.1%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets49.7%
Debt / equity0.37x
Current ratio2.04x
Interest coverage-1.79x

Cash quality & payout

Operating cash flow / net income-0.06x
Accruals ratio-19.9%
Payout ratio—
Capex / revenue3.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$311.01M$320.11M$320.61M$370.32M$364.21M$386.14M$364.49M$445.55M
Cost of revenue$108.84M$101.79M$106.14M$108.34M$107.49M$120.41M$117.53M$166.41M
Gross profit$202.17M$218.32M$214.46M$261.98M$256.72M$265.73M$246.96M$279.15M
SG&A expense$93.87M$90.85M$98.54M$107.39M$104.82M$106.72M$113.20M$120.93M
Operating income$5.09M-$59.32M$4.03M$23.24M$21.64M$30.78M-$9.90M-$53.08M
Interest expense$3.50M$3.32M$4.25M$3.99M$4.14M$2.53M$3.28M$5.86M
Pretax income$1.89M-$63.17M$2.60M$18.19M$15.99M$27.41M$134.60M-$57.80M
Income tax$2.63M$186.62M$763,000$3.70M-$1.08M$6.29M$27.09M-$21.70M
Net income-$742,000-$249.80M$1.84M$14.49M$17.08M$21.12M$107.52M-$36.10M
EBITDA$17.62M-$46.66M$16.37M$36.16M$33.73M$43.83M$4.30M-$36.63M
EPS (basic)-0.02-5.140.04—0.350.432.16—
EPS (diluted)-0.02-5.140.04—0.340.432.14—
Weighted avg. shares (diluted)48.68M48.60M49.42M—50.31M49.50M50.33M—
Balance sheet
Cash & equivalents$164.90M$189.64M$198.65M$238.63M$251.79M$264.16M$203.77M$186.88M
Short-term investments$1.74M$1.74M$1.75M$1.21M$1.21M$1.21M$9.78M$11.11M
Receivables$51.41M$48.90M$45.01M$39.54M$48.89M$59.70M$56.58M$50.78M
Inventory$191.66M$191.50M$178.60M$178.64M$178.53M$180.38M$188.78M$190.24M
Current assets$479.42M$508.15M$522.89M$547.70M$548.14M$571.55M$524.86M$538.60M
PP&E, net$382.94M$379.55M$381.61M$377.17M$375.28M$374.21M$380.07M$379.60M
Goodwill$4.75M$4.75M$83.62M$83.62M$83.62M$83.62M$83.62M$83.62M
Intangibles$36.38M$37.88M$39.29M$42.61M$44.20M$45.94M$47.55M$74.28M
Total assets$1.09B$1.12B$1.38B$1.41B$1.42B$1.44B$1.39B$1.47B
Current liabilities$235.19M$256.35M$257.00M$263.73M$254.44M$283.91M$260.30M$296.61M
Short-term debt$20.00M$20.00M$20.00M$20.00M$20.00M$35.00M$20.00M$30.00M
Long-term debt$183.73M$193.66M$203.59M$204.19M$209.04M$213.90M$218.76M$363.61M
Total debt$203.73M$213.66M$223.59M$224.19M$229.04M$248.90M$238.76M$393.61M
Total liabilities$540.60M$578.79M$582.71M$600.07M$624.61M$655.94M$637.44M$817.46M
Shareholders' equity$547.48M$542.74M$794.09M$805.24M$799.79M$787.75M$753.97M$651.46M
Net debt$38.83M$24.02M$24.94M-$14.44M-$22.74M-$15.26M$34.99M$206.73M
Cash flow statement
Operating cash flow-$8.12M$10.62M-$3.92M$16.62M$27.48M$35.80M$389,000$25.79M
Capital expenditure$11.35M$5.64M$13.71M$10.76M$9.91M$18,000$13.58M$12.58M
Free cash flow-$19.47M$4.99M-$17.63M$5.86M$17.57M$35.78M-$13.20M$13.20M
Investing cash flow-$5.15M-$5.64M-$14.29M-$9.76M-$9.91M$8.79M$181.54M-$13.62M
Financing cash flow-$13.47M-$13.38M-$20.40M-$18.50M-$26.88M$9.27M-$166.29M-$43.63M
Depreciation & amortization$12.54M$12.66M$12.34M$12.91M$12.09M$13.05M$14.21M$16.45M
Stock-based compensation$2.71M$1.12M$3.69M$3.16M$5.82M$5.82M$5.20M$3.44M
Dividends paid$2.93M$2.91M$2.87M$2.91M$2.96M$2.96M$3.00M$2.98M
Share buybacks$0$0$5.01M$10.02M$5.01M$0$5.01M$0

Free plan shows the latest 8 periods; Pro shows all 71 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.